Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates

被引:25
作者
Hall, D
Ybazeta, G
Destro-Bisol, G
Petzl-Erler, ML
Di Rienzo, A
机构
[1] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
[2] Univ Roma La Sapienza, Dipartimento Biol Anim & Uomo, Rome, Italy
[3] Univ Fed Parana, Dept Genet, BR-80060000 Curitiba, Parana, Brazil
[4] Univ Cattolica Sacro Cuore, Ist Med Legale, Rome, Italy
来源
PHARMACOGENETICS | 1999年 / 9卷 / 05期
关键词
glucuronidation; bilirubin; natural selection; oxidative damage;
D O I
10.1097/00008571-199910000-00006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Variation at the UDP-glucuronosyltransferase (UGT) 1A1 gene promoter is present in humans. Variable numbers of TA repeats in the TATA box of this gene are found which are inversely related to levels of gene expression. We investigated this polymorphism in 658 individuals from a worldwide sample of 15 aboriginal and two admired human populations, This study shows that there is a great deal of variability across ethnic groups with regard to UGT1A1 allele frequencies, with the most common allele varying in frequency from 33% to 91%. Populations of African origin harbor four different alleles while non-African populations appear to have only two alleles. In addition, alleles associated with lower gene expression levels reach the highest frequencies in populations of African origin and lowest among Asians and Amerindians. Thus, more variability in the metabolism of drugs eliminated by UGT1A1 glucuronidation should be expected in populations of Sub-Saharan African origin. The sequence analysis of nine primate species shows that the number of TA repeats has increased during primate evolution achieving the largest number in humans, We suggest that the UGT1A1 promoter variability does not reflect historical relationships between populations and that it may be maintained by natural selection. Our findings are consistent with the proposal that the TA repeat variation is a balanced polymorphism. Pharmacogenetics 9:591-599 (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 46 条
[1]   The UGT1A1*28 allele is relatively rare in a Japanese population [J].
Ando, Y ;
Chida, M ;
Nakayama, K ;
Saka, H ;
Kamataki, T .
PHARMACOGENETICS, 1998, 8 (04) :357-360
[2]   Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter:: A balanced polymorphism for regulation of bilirubin metabolism? [J].
Beutler, E ;
Gelbart, T ;
Demina, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8170-8174
[3]   THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME [J].
BOSMA, PJ ;
CHOWDHURY, JR ;
BAKKER, C ;
GANTLA, S ;
DEBOER, A ;
OOSTRA, BA ;
LINDHOUT, D ;
TYTGAT, GNJ ;
JANSEN, PLM ;
ELFERINK, RPJO ;
CHOWDHURY, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1171-1175
[4]   SEQUENCE OF EXONS AND THE FLANKING REGIONS OF HUMAN BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE GENE-COMPLEX AND IDENTIFICATION OF A GENETIC MUTATION IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME, TYPE-I [J].
BOSMA, PJ ;
CHOWDHURY, NR ;
GOLDHOORN, BG ;
HOFKER, MH ;
ELFERINK, RPJO ;
JANSEN, PLM ;
CHOWDHURY, JR .
HEPATOLOGY, 1992, 15 (05) :941-947
[5]   HIGH-RESOLUTION OF HUMAN EVOLUTIONARY TREES WITH POLYMORPHIC MICROSATELLITES [J].
BOWCOCK, AM ;
RUIZLINARES, A ;
TOMFOHRDE, J ;
MINCH, E ;
KIDD, JR ;
CAVALLISFORZA, LL .
NATURE, 1994, 368 (6470) :455-457
[6]   ALTERATION OF DRUG-METABOLISM IN GILBERTS SYNDROME [J].
CARULLI, N ;
PONZDELEON, M ;
MAURO, E ;
MANENTI, F ;
FERRARI, A .
GUT, 1976, 17 (08) :581-587
[7]   Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7 [J].
Cheng, ZQ ;
Rios, GR ;
King, CD ;
Coffman, BL ;
Green, MD ;
Mojarrabi, B ;
Mackenzie, PI ;
Tephly, TR .
TOXICOLOGICAL SCIENCES, 1998, 45 (01) :52-57
[8]  
CLARKE DJ, 1994, HDB EXPT PHARM, V112, P3
[9]   ANALYSIS OF BETA-THALASSEMIA MUTATIONS IN THE UNITED-ARAB-EMIRATES PROVIDES EVIDENCE FOR RECURRENT ORIGIN OF THE IVSI NT-5 (G-C) MUTATION [J].
DELEO, R ;
DEIDDA, G ;
NOVELLETTO, A ;
ELKALLA, S ;
MATHEWS, AR ;
FELICETTI, L .
HUMAN MUTATION, 1995, 5 (04) :327-328
[10]   DECREASED GLUCURONIDATION AND INCREASED BIOACTIVATION OF ACETAMINOPHEN IN GILBERTS-SYNDROME [J].
DEMORAIS, SMF ;
UETRECHT, JP ;
WELLS, PG .
GASTROENTEROLOGY, 1992, 102 (02) :577-586